Results 21 to 30 of about 129,985 (296)
Viruses, 2023 Phage endolysin-specific binding characteristics and killing activity support their potential use in biotechnological applications, including potency and purity testing of live biotherapeutic products (LBPs).
Robert J. Dorosky +5 more
doaj +1 more source
Vaccines against human enteric bacterial pathogens [PDF]
, 2002 The development of vaccines against enteric bacterial pathogens presents a challenge because of the large number of pathogens capable of causing disease and the requirement to induce immunity that is effective in the gut.
Huett, Alan +2 more
core +1 more source
Virus-like Particle Vaccines and Platforms for Vaccine Development [PDF]
, 2023 Virus-like particles (VLPs) have gained a lot of interest within the past two decades. The use of VLP-based vaccines to protect against three infectious agents—hepatitis B virus, human papillomavirus, and hepatitis E virus—has been approved ...
Hong Liu +2 more
core +1 more source
Dose-specific efficacy of Haemophilus influenzae type b conjugate vaccines: a systematic review and meta-analysis of controlled clinical trials. [PDF]
, 2012 Global coverage of infant Haemophilus influenzae type b (Hib) vaccination has increased considerably during the past decade, partly due to GAVI Alliance donations of the vaccine to low-income countries. In settings where large numbers of children receive
Clark, A +6 more
core +1 more source
Vaccines against bacterial meningitis [PDF]
British Medical Bulletin, 2004 Meningitis remains an important cause of morbidity and mortality among children >5 years of age and is especially prevalent in developing countries. Effective routine immunization against Hib, pneumococcus and serogroupC meningococcus has had a significant impact on both invasive disease and carriage caused by these encapsulated bacteria.
Segal, S, Pollard, A
openaire +3 more sources
Biological safety concepts of genetically modified live bacterial vaccines [PDF]
, 2007 Live vaccines possess the advantage of having access to induce cell-mediated and antibody-mediated immunity; thus in certain cases they are able to prevent infection, and not only disease. Furthermore, live vaccines, particularly bacterial live vaccines,
Frey, Joachim
core +1 more source
Биопрепараты: Профилактика, диагностика, лечение, 2022 Diseases caused by Streptococcus pneumoniae, as well as antibiotic resistance of its serotypes, are the leading cause of death amongst children worldwide.
V. P. Trukhin +5 more
doaj +1 more source
Журнал микробиологии, эпидемиологии и иммунобиологии, 2018 Aim. The research was aimed at evaluating the reactogenicity, safety and immunogenicity of Flu-M inactivated split influenza vaccine. Materials and methods.
I. V. Feldblyum +11 more
doaj +1 more source
EClinicalMedicine, 2021 Background: Shigellosis accounts for substantial morbidity and mortality worldwide and is the second most common cause of moderate and severe diarrhoea in children.
Robert W. Frenck, Jr +23 more
doaj +1 more source
Bacterial Spores as Vaccine Vehicles [PDF]
Infection and Immunity, 2003 ABSTRACT For the first time, bacterial spores have been evaluated as vaccine vehicles. Bacillus subtilis spores displaying the tetanus toxin fragment C (TTFC) antigen were used for oral and intranasal immunization and were shown to generate mucosal and systemic responses in a murine model.
DUC L. H. +4 more
openaire +3 more sources